# Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid Tumors

> **NCT00028405** · PHASE1 · COMPLETED · sponsor: **Light Sciences LLC** · enrollment: 48 (—)

## Conditions studied

- Liver Metastasis
- Pelvic Cancer
- Head and Neck Cancer
- Sarcoma
- Rectal Cancer
- Breast Cancer
- Colorectal Cancer
- Mouth Cancer

## Interventions

- **DRUG:** LS 11(Taporfin Sodium)
- **DEVICE:** Lumaflex Light Delivery Catheter

## Key facts

- **NCT ID:** NCT00028405
- **Lead sponsor:** Light Sciences LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-11
- **Primary completion:** —
- **Final completion:** 2002-12
- **Target enrollment:** 48 (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00028405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00028405, "Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid Tumors". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00028405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
